ProShares Ultra Nasdaq Biotechnology Price & Performance (BIB)

ProShares UltraPro Short QQQ has experienced a notable 20.9% increase in short interest as of March 31, now totaling over 14 million shares. This uptick reflects heightened bearish sentiment and could increase volatility as traders position around the ETF’s leveraged exposure to the Nasdaq-100 index.12

Several hedge funds and institutional players have significantly increased their stakes in ProShares UltraPro Short QQQ. Notable new positions and expanded holdings suggest growing interest in leveraged bearish bets on the Nasdaq-100, even as the ETF’s dividend yield remains above 5%.21

Despite a recent gap-down in share price, ProShares UltraPro Short QQQ maintains a strong annualized dividend yield near 5%. The ETF’s recent payout and continued institutional accumulation highlight its ongoing appeal for income-focused and tactical investors navigating volatile tech markets.21